title: Acute drug-induced vascular injury in beagle dogs: pathology and correlating genomic expression.
abstract: Acute vascular injury that leads to vascular inflammation is a common finding in the preclinical toxicity testing of drugs in rats and dogs. However, the relevance of this finding for risk to humans is unclear. Concern about the safety of these drugs is heightened by the current lack of noninvasive clinical methods to predict the onset of vascular damage in animals or humans. Determining the relevance of this poorly understood preclinical outcome for humans requires a better understanding of the molecular mechanisms of injury in addition to the development of sensitive and specific leading biomarkers for the clinical diagnosis of acute vascular damage. Most molecular research on this toxicity has been performed in rats, but recent development of canine gene expression microarrays makes transcriptomic studies now possible in the dog. In this study, we investigated the molecular mechanisms of drug-induced vascular injury in dogs using gene arrays. After treating Beagles with toxic doses of CI-947, an adenosine receptor agonist, we profiled gene expression in the coronary arteries and correlated those changes with histopathology at 16 and 24 hours after dosing. The results demonstrated that pathobiological processes such as stimulation of the innate immune response, increased extracellular matrix turnover and oxidative stress were active at times of very early injury.
authors.affiliation: Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut 06536, USA.
authors.forename: Bradley E
authors.initials: BE
authors.lastname: Enerson
authors.forename: Aiping
authors.initials: A
authors.lastname: Lin
authors.forename: Bin
authors.initials: B
authors.lastname: Lu
authors.forename: Hongyu
authors.initials: H
authors.lastname: Zhao
authors.forename: Michael P
authors.initials: MP
authors.lastname: Lawton
authors.forename: Eugenia
authors.initials: E
authors.lastname: Floyd
mesh_terms: D000208:Acute Disease; D000241:Adenosine / Q000031:analogs & derivatives* / Q000633:toxicity; D000284:Administration, Oral; D000818:Animals; D015415:Biomarkers; D003331:Coronary Vessels / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D015870:Gene Expression / Q000187:drug effects; D020869:Gene Expression Profiling / Q000379:methods*; D023281:Genomics; D008297:Male; D020411:Oligonucleotide Array Sequence Analysis; D058906:Purinergic P1 Receptor Agonists; D018675:Toxicity Tests / Q000379:methods*; D014657:Vasculitis / Q000139:chemically induced* / Q000235:genetics / Q000473:pathology
chemical_list: D015415:Biomarkers; D058906:Purinergic P1 Receptor Agonists; C071201:N-(2,3-dihydro-1H-inden-1-yl)adenosine; D000241:Adenosine